Erythropoietin, a glycoprotein that regulates erythropoiesis, initiates its biological effects by binding to a cell-surface receptor. Little is known about the structure of the erythropoietin receptor and the events that follow binding of erythropoietin to its receptor, in part because of the difficulty of obtaining sufficient quantities of cells that express the erythropoietin receptor. We used both iodinated and metabolically labeled erythropoietin to characterize the receptor on a variety of erythroleukemia cell lines not previously tested, and we have identified both human and murine cell lines that display large numbers of erythropoietin receptors. Both erythropoietin-responsive and -nonresponsive cell lines exhibit a single class of binding sites. The human erythroleukemia cell line OCIM1 exhibits =3000 erythropoietin receptors per cell with a Kd of 280 pM. The erythropoietin-responsive Rauscher red 5-1.5 murine erythroleukemia cell line displays %1700 receptors per cell with a Kd of 440 pM. The GM979 murine erythroleukemia cell line has -1600 receptors per cell with aKd of 660 pM. Induction of the erythroid phenotype by dimethyl sulfoxide or its suppression by phorbol 12-myristate 13-acetate was accompanied by an increase or decrease, respectively, in erythropoietin receptor number. Affinity crosslinking of labeled erythropoietin to the receptor identified two proteins corresponding to estimated molecular masses of 95 and 105 kDa. The OCIM1, Rauscher, and GM979 erythroleukemia cell lines provide a useful model for the study of postreceptor signaling events, as well as a convenient source for purification of the erythropoietin receptor.
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Erythropoietin is required for the survival, proliferation, and terminal maturation of normal erythroid cells. Erythropoietin is necessary for the growth of erythroid colony-forming cells in vitro (1) and stimulates transcription of the globin genes (2) as well as production of other major erythrocyte proteins (3) . Binding sites for erythropoietin have been identified on erythropoietin-responsive erythroid precursor cells derived from the spleens of mice infected with the anemia strain of Friend virus (FVA cells) (4-6); on erythroid colony-forming cells obtained from phenylhydrazine-treated mice or fetal mouse or rat liver (7) (8) (9) ; and on the murine hematopoietic cell lines MEL, DA-1, SKT6, and TSA8 (5, (10) (11) (12) . Human erythroid colony-forming cells and the human erythroleukemia cell line K562 also exhibit erythropoietin binding sites (13, 14) . Data on erythropoietin binding to plasma membranes from FVA cells were interpreted in terms of two classes of binding sites, one with high and one with low binding affinity (6) . Similar data were reported for intact FVA cells (5) , and other investigators have identified two classes of erythropoietin receptors on colony-forming cells derived from fetal mouse liver cells (8) . In contrast, a single class of binding sites was found on MEL, DA-1, SKT6, and K562 cells, as well as rat fetal liver cells (5, 7, (9) (10) (11) 14) . While FVA cells displayed a total of 800-1000 binding sites per cell (5, 6) , the erythroid colony-forming cells isolated from the erythropoietin-responsive murine cell lines DA-1 and SKT6 display approximately 130 and 470 receptors per cell, respectively (10, 11 (15) . The purified protein has a specific activity of 129,000 units per mg of glycoprotein as determined by in vivo 59Fe uptake bioassay (16) . Erythropoietin from the same source, labeled on tyrosine with 1251 (1251-erythropoietin) was a product of Amersham (specific radioactivity, 300-900 Ci/mmol; 1 Ci = 37 GBq). The specific radioactivity of the 125I-erythropoietin was assessed for these experiments by Scatchard analysis using a RIA for the determination of the molar concentration of 1251-erythropoietin (17) . The specific radioactivities determined by this method were used for the binding studies presented here. In addition, to confirm that the method of labeling does not (26) . This yielded best-fit values for the total numbers of binding sites, the dissociation constant, and the fraction of medium trapped in the extracellular space of the cell pellet. With these parameters, free and bound forms of the hormone were computed, and the results are presented in Scatchard plot format. For comparison, results were also evaluated by the commonly used method of correcting the raw data for "'nonspecific binding" before interpretation. For this method of data analysis, nonspecific binding was estimated by including a 100-fold excess of unlabeled erythropoietin. Specific binding was calculated as the difference between total and nonspecific binding. This correlation is actually one for trapping labeled hormone in the cell pellet (26) .
Internalization and Degradation of Erythropoietin. To determine whether erythropoietin was internalized after binding to its cell-surface receptor at 15'C, cells were incubated with 0.3 nM 125I-erythropoietin for 3 hr. The cells were washed with binding medium and then treated with 0.05 M glycine hydrochloride (pH 3.0) containing 0.15 M NaCl for 5 min in an ice bath to dissociate surface-bound erythropoietin (7) . The cells were centrifuged to separate cell pellets (internalized erythropoietin) and supernatants (surfacebound erythropoietin). Degradation of erythropoietin was monitored by the loss of precipitability of 125I by trichloroacetic acid in the incubation medium. A 10% solution of trichloroacetic acid will precipitate 125I-erythropoietin but not 125I-labeled peptides resulting from lysosomal degradation.
Affinit Crosslinking of '25I-Erythropoietin to Its Receptor.
125I-erythropoietin was crosslinked to its receptor on the surface ofRauscher red 5-1.5 cells to determine the molecular mass and subunit structure of the receptor. Rauscher cells (8 x 106 cells) were incubated with 12 nM 125I-erythropoietin in a total vol of 1 ml of binding buffer for 3 hr at 15°C. A parallel sample contained, in addition, a 100-fold excess of unlabeled erythropoietin. The cells were washed twice with phosphatebuffered saline (PBS) and then resuspended in 1 ml of PBS containing 0.3 mM disuccinimidyl suberate (Pierce) (27) . After a 4-hr incubation at 4°C, the cells were washed twice with PBS, and then resuspended in 0.1 ml of sample buffer, boiled for 3 min, and subjected to electrophoresis on an 8% NaDodSO4/polyacrylamide gel (28 Fig. 1; Table 1 ).
Several murine and human erythroleukemia cell lines and the human myeloid leukemia cell line KG-1 were screened for expression of erythropoietin receptors, and full equilibrium binding experiments were performed on selected cell lines ( Table 1 ). The erythropoietin-responsive and erythropoietinunresponsive subclones of Rauscher cells had a similar number of binding sites and Kd, indicating that the inability of the nonresponsive subclone to respond to erythropoietin was not due to an alteration in receptor numbers or affinity, but must result from a postbinding deficiency. The murine erythroleukemia cell line GM979 expressed 1635 erythropoietin receptors per cell (Fig. 2) . Data (Fig. 3) . In this experiment, PMA caused a decrease in the number of erythropoietin receptors per cell from 2210 to 370 without altering the affinity of the receptor for erythropoietin (Fig. 3) . In two additional experiments, PMA treatment of OCIM1 cells resulted in a 50%o and 62% reduction in the number of erythropoietin receptors expressed per cell without a significant change in the Kd. In contrast to the results with PMA, Me2SO was found to increase the binding oferythropoietin to GM979 cells. Uninduced GM979 cells expressed 1635 receptors per cell with a Kd of 660 pM (Table 1 ; Fig. 2) . After a 4-day incubation with 1% Me2SO, there were 8380 receptors per cell with a Kd of 1.1 nM (Fig. 2) . To determine whether Me2SO treatment increased cellular hemoglobin content, GM979 cells were stained with benzidine. Uninduced GM979 cells were uniformly benzidine negative, but GM979 cells induced with Me2SO for 4 days were 38% benzidine positive. Thus, Me2SO induced terminal erythroid differentiation including an increased display of the erythropoietin receptor in these cells.
Affinity Crosslinking of 125I-Erythropoietin to Its Receptor. 12'I-erythropoietin was crosslinked to its receptor on Rauscher red 5-1.5 cells with disuccinimidyl suberate, and crosslinked proteins were analyzed by NaDodSO4/PAGE followed by autoradiography (Fig. 4) . Under reducing conditions, two radioactive bands with apparent molecular masses of 145 and 135 kDa were detected. When a 100-fold excess of unlabeled erythropoietin was included in the reaction mixture, no bands were seen. Essentially identical results were obtained in the absence of the reductant, suggesting a lack of interchain and a low content of intrachain disulfide bridges. Since erythropoietin migrated at 40 kDa on this gel, the receptor subunits have apparent molecular masses of about 105 and 95 kDa when corrected for the molecular mass of erythropoietin.
DISCUSSION
Conditions under which binding of erythropoietin to erythroleukemia cells could be reliably quantitated were identified. Conducting binding experiments at 150C allows erythropoietin-receptor interactions to be examined in the absence of significant internalization and degradation of erythropoietin during the time required to reach binding equilibrium. The experimental method was designed to avoid disturbing bind- Erythropoietin Bound (pM) ing equilibrium before measurement, a frequent cause of artifactual complexity of binding data. Finally, a rigorous statistical method of data analysis (26) was used to obtain an estimate of binding parameters in an attempt to distinguish a single class from two classes of binding sites.
A number of cell lines demonstrated erythropoietin binding. In each case, erythropoietin binding was best described as a single class ofbinding sites. This held true at both pH 7.4 and pH 8, although the equilibrium constant and number of binding sites identified per cell differed at pH 7.4 and pH 8. Observation of a single class of binding sites at both pH 7.4 and pH 8 argues for the presence of a single type of binding molecule. It is unlikely that the constants describing two classes of binding sites (even if fortuitously identical at a particular pH), would change by the same amount on changing the pH, unless the two sites are essentially identical. These results argue against major binding site heterogeneity. A single class ofbinding sites for erythropoietin has also been reported for most other cells (7, (9) (10) (11) 14) . Together with the evidence for binding site homogeneity, these observations argue strongly that the binding sites identified in this report are erythropoietin receptors. The observation of Mufson and Gesner (7) that erythropoietin from which sialic acid residues had been enzymatically removed shows both increased affinity for the binding sites and increased in vitro biological activity when compared with fully sialated erythropoietin adds to this argument.
The receptor on Rauscher red 5-1.5 cells was characterized by affinity crosslinking with 125I-erythropoietin followed by NaDodSO4/PAGE. Two crosslinked bands ofapproximately equal density were observed with '"'I-erythropoietin, but not in the presence of a 100-fold molar excess of unlabeled erythropoietin. After correction for the apparent molecular mass of erythropoietin, the receptor subunits were estimated to have apparent molecular masses of 105 and 95 kDa. A doublet of affinity-crosslinked proteins was also reported in FVA cells and rat erythroid precursor cells (6, 9 (29) . Phorbol esters can modulate the receptors for a number of growth factors, including macrophage colony-stimulating factor (30) , insulin (31) , and epidermal growth factor (32) by stimulating synthesis of the receptor or enhancing its internalization. We found that treatment of OCIM1 cells with PMA for 24 hr resulted in a decrease by a factor of 2-6 in the number of erythropoietin receptors (Fig. 3) . Phorbol esters decrease the display of late erythroid-specific markers on K562 cells (33) and down-modulate the expression of the erythroid phenotype in HEL (34) and OCIMi cells (18) . Thus, the loss of erythropoietin receptors induced by PMA parallels the decrease in other erythroid markers. In addition, Me2SO was found to increase the expression of erythropoietin receptors on GM979 cells. GM979 cells cultured with Me2SO exhibited 5-fold more erythropoietin receptors per cell than uninduced GM979 cells (Fig. 2) . Terminal erythroid differentiation (indicated by hemoglobin production) accompanied the increased display of erythropoietin receptors in Me2SO-treated GM979 cells, in contrast to the results of Noguchi et al. (35) .
The OCIM1, Rauscher, and GM979 cell lines provide homogeneous populations of receptor-bearing cells and thus may be useful as a readily available source for the purification of the erythropoietin receptor. The erythropoietin-responsive Rauscher red 5-1.5 cell line should also be useful for the investigation ofputative transmembrane signaling events that occur after erythropoietin binding, including calcium mobilization (36) and changes in phosphorylation of membrane proteins (37) .
